Nordson Stock Earnings Reports

Nordson delivered a strong fiscal Q2 2026: record sales of $741M (up 8% YoY) driven by 7% organic growth across all three segments, record EBITDA of $235M (32% margin) and record adjusted EPS of $2.86 (up 18% YoY). Order entry remained robust, pushing backlog up 18% organically. Free cash flow was $170M (119% conversion of net income excluding certain noncash items), enabling balanced capital deployment: dividends, $43M of share repurchases, $93M net debt reduction, and a bolt-on acquisition (CapstanAG) to expand precision agriculture in North America. Management completed a pension annuitization (roughly $113M of U.S. obligation) with no cash outlay, improving funded status and lowering ongoing pension cost. Segment highlights: Industrial Precision Solutions returned to normalized growth with improving coatings and polymer demand; Medical & Fluid Solutions showed 8% organic growth with a near-term interventional product start-up/regulatory change impacting margins but expected to normalize; Advanced Technology Solutions (ATS) posted all-time quarterly sales and backlog strength driven by electronics/semiconductor demand (dispense and test & inspection). Management raised full-year guidance: sales to $2.93B–$3.01B and adjusted EPS to $11.30–$11.80, with high confidence in the midpoint and upside if current demand is sustained. Key risks noted include macro volatility and potential impacts on customer order activity, and certain noncash accounting charges affecting GAAP results.